Published on 5 Mar 2024 on Zacks via Yahoo Finance
Gritstone bio Inc. (GRTS) Reports Q4 Loss, Tops Revenue Estimates
Gritstone bio Inc. (GRTS) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to loss of $0.30 per share a year ago. These figures are adjusted for non-recurring items.
This quarterly report represents an earnings surprise of 27.78%. A quarter ago, it was expected that this company would post a loss of $0.35 per share when it actually produced a loss of $0.33, delivering a surprise of 5.71%.
Over the last four quarters, the company has surpassed consensus EPS estimates four times.